Company intelligence / Profile preview

Parke-Davis

Detroit, Michigan, United Statesen.wikipedia.org ↗
Ownership
Private
Development stage
Commercial
01

Overview

Once the world’s largest pharmaceutical company and a pioneer in drug standardization, clinical trials, and vaccine development. Notable products included Dilantin for epilepsy, the first bacterial vaccine in the US, Benadryl antihistamine, Chloromycetin antibiotic, oral contraceptives, PCP and ketamine anesthetics. The company was acquired by Warner-Lambert in 1970 and became part of Pfizer after Pfizer’s acquisition of Warner-Lambert in 2000[1][5][6].

Therapeutic areas
EndocrinologyNeurologyInfectious Diseases
Modalities
Small molecules (historically)Vaccines/biologics (historically)
Industry
Pharma
02

Drug pipeline

4 assets

phenytoin sodium

Commercial
Indications
generalized tonic-clonic seizure, temporal lobe epilepsy (TLE), post-traumatic seizure (PTS), generalized tonic-clonic status epilepticus (GTCSE) / generalized convulsive status epilepticus (GCSE), seizure disorders and seizure emergencies, focal impaired awareness seizure (FIAS)

3 more assets in the full pipeline.

Request access →
03

Partnerships

Daiichi Sankyo Co. (co-development of Rezulin)[1]Glaxo Wellcome (co-development of Rezulin)[1]

Beyond the preview

Go deeper on Parke-Davis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parke-Davis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call